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To determine the role of endogenous interleukin-10 (IL-10) in local host defense during pneumococcal
meningitis, the inflammatory responses of IL-10-gene-deficient and wild-type mice after the induction of
meningitis were compared. The absence of IL-10 was associated with higher cytokine and chemokine concen-
trations and a more pronounced infiltrate, but antibacterial defense or survival was not influenced.
Streptococcus pneumoniae is a major pathogen in bacterial
meningitis in developed countries (22). Knowledge of the
pathogenesis of pneumococcal meningitis is important not only
because of the severity of the disease but also because resis-
tance to penicillin and other antimicrobial agents has increased
dramatically during the past decade (2, 3, 15).
Interleukin-10 (IL-10) is a pleiotropic, homodimeric cyto-
kine produced by a large variety of cells, including monocytes/
macrophages, B and T lymphocytes, and resident brain cell
populations such as microglia and neurons (7, 21). IL-10 is
considered a prototypic anti-inflammatory cytokine and po-
tently inhibits the production of proinflammatory cytokines in
vitro and in vivo (13, 14, 16, 18, 20).
Elevated levels of IL-10 have been found in the cerebrospi-
nal fluid (CSF) of patients with bacterial (10, 24), aseptic (6, 8),
cryptococcal (4, 6), and tuberculous (12) meningitis. Autoan-
tibodies against IL-10 have been found in CSF from rats with
experimental bacterial meningitis and are considered to play a
regulatory role in the cytokine cascade (1). However, knowl-
edge of the role of IL-10 in bacterial meningitis is highly
limited. Therefore, in the present study, we induced pneumo-
coccal meningitis in IL-10-gene-deficient (IL-10/) C57BL/6
mice (Jackson Laboratory, Bar Harbor, Maine) whose sex
matched that of the C57BL/6 wild-type (WT) mice (Harlan
Spaque Dawley, Inc., Horst, The Netherlands) used. All mice
were inoculated at 3 to 4 weeks of age. Each experimental
group consisted of 14 mice per time point; 22 mice per group
were inoculated for survival analysis. All animal experimenta-
tion guidelines were followed in animal studies. Meningitis was
induced as described previously (25). Briefly, the mice were
lightly anesthetized by inhalation of isoflurane (Abott, Queens-
borough, Kent, United Kingdom), and 50 l of inoculum (8 
104 CFU of S. pneumoniae type 6A plus 180 U of hyaluroni-
dase [Sigma, St. Louis, Mo.]) was inoculated intranasally. The
control mice were inoculated with isotonic saline. At 24, 48, or
72 h after inoculation, the mice were sacrificed and blood,
CSF, and brains were collected. Leukocytes in the CSF were
counted immediately, and bacterial outgrowth in CSF and
blood was determined by serial dilutions onto blood agar
plates. The brains were removed; one-half of each brain was
fixed in 10% buffered formalin for histopathologic study, while
the other half was homogenized in sterile saline, plated on
blood agar to determine bacterial outgrowth, and incubated
with lysis buffer (300 mM NaCl, 15 mM Tris, 2 mM MgCl2, 2
mM CaCl2, 2 mM Triton X-100, pepstatin A [20 ng/ml], leu-
peptin [20 ng/ml], aprotinin [20 ng/ml], pH 7.4). Levels of
cytokines were measured in supernatants from brain homoge-
nates by using commercially available enzyme-linked immuno-
specific assays, according to the recommendations of the man-
ufacturers (IL-1, KC, macrophage inflammatory protein 2,
and tumor necrosis factor alpha [TNF-], from R&D Systems,
Minneapolis, Minn., and IL-6 and IL-10 from Pharmingen, San
Diego, Calif.). Data are expressed as means  standard errors
of the means. Statistical analysis was performed by using the
Mann-Whitney U test and the Kaplan-Meier test. P values of
0.05 were considered significant.
The induction of meningitis was associated with an upregu-
lation of IL-10 in brain tissue (Fig. 1). At 24, 48, and 72 h after
inoculation, higher percentages of inoculated IL-10/ mice
had developed meningitis than had the WT mice (at 24 h, 21
versus 29%; at 48 h, 71 versus 54%; at 72 h, 79 versus 64%,
respectively; all differences were not significant). To determine
the role of IL-10 in early host defense, we evaluated bacterial
outgrowth in the CSF and blood of WT and IL-10/ mice
with meningitis. The bacterial counts determined for the CSF,
brain homogenates, and blood from the IL-10/ and WT
mice were similar (Table 1). Bacterial meningitis is character-
ized by a pleocytosis of CSF. Although the number of leuko-
cytes in the CSF from the IL-10/ and WT mice did not differ
significantly [at 24 h, (2.7 1.5) 105 versus (2.0 1.0) 104
cells/ml; at 48 h, (1.3  0.5)  106 versus (0.5  0.4)  106
cells/ml; at 72 h, (3.8  2.0)  106 versus (2.5  1.1)  106
cells/ml, respectively; no differences were significant], histo-
logic examination of their respective brain tissues showed a
more pronounced inflammatory infiltrate around the meninges
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in IL-10/ than around those of the WT mice. At 24 h after
inoculation, the WT mice showed only a slight influx of leuko-
cytes (Fig. 2A), whereas the meningeal infiltrate, mainly con-
sisting of neutrophils, in IL-10/ mice was moderate (Fig.
2B). To gain further insight into the role of IL-10 in the local
inflammatory response, we measured proinflammatory cyto-
kines and chemokines in brain tissue. At 24 h after inoculation,
no significant differences in cytokine and chemokine concen-
trations were found between IL-10/ and WT mice; however,
at 48 h after inoculation, IL-6, TNF-, and KC levels were
significantly higher in the brain tissues from the IL-10/ mice
than in those from the WT mice (Fig. 3). IL-1 was also
elevated in IL-10/ mice, but the difference did not reach
statistical significance; the levels of macrophage inflammatory
protein 2 in the IL-10/ and WT mice were not different
(data not shown). To determine the role of endogenous IL-10
beyond the early phase of the infection, survival was observed
for 3 weeks after inoculation; no significant difference between
the IL-10/ and the WT mice was observed (hazard ratio,
0.65; 95% confidence interval, 0.28 to 1.5; P 	 0.29). Because
more IL-10/ mice than WT mice developed meningitis after
inoculation, we also determined the survival times of all non-
survivors and found them to be comparable for the IL-10/
and WT mice (3.3  0.6 days [mean  standard errors of the
means] [range, 1.6 to 9.6] versus 3.8  1.4 days [range, 1.9 to
13.6], respectively; no differences were significant).
The IL-10/ mice demonstrated an increased immune re-
sponse as reflected by a more pronounced inflammatory infil-
trate around the meninges and higher concentrations of proin-
flammatory cytokines and chemokines in brain tissue. These
observations are in line with those of previous studies in which
treatment with IL-10 attenuated the release of proinflamma-
tory cytokines during experimental bacterial meningitis (9, 19).
The local inflammatory response is considered to play an im-
portant role in tissue damage and death during meningitis.
However, in this model, the increased inflammatory response
in the IL-10/ mice did not result in significantly impaired
survival. As far as the effects of IL-10 on bacterial clearance are
concerned, it has been shown that this cytokine directly inhibits
neutrophil and macrophage phagocytic and bactericidal activ-
ities in vitro (11, 17). However, in two recent studies, a limited
role for IL-10 in antibacterial defense in the central nervous
system has been demonstrated. Control of bacteria was un-
changed in IL-10/ mice intracerebrally challenged with Lis-
teria monocytogenes (5), and IL-10 treatment only slightly de-
layed bacterial clearance in an experimental rabbit model of
Haemophilus influenzae meningitis (19). Interestingly, endoge-
nous IL-10 was previously shown to impair antibacterial host
defense mechanisms during pneumococcal pneumonia (23).
The effect of IL-10 on in vivo phagocytosis and killing of
microorganisms during meningitis may be different, in partic-
ular since the central nervous system is a compartment of the
body in which the immune response is determined by the
FIG. 1. IL-10 concentrations in brain tissue during meningitis.
IL-10 expression levels (means  standard errors) in brain homoge-
nates of NaCl-injected WT mice and WT mice with meningitis at 24,
48, and 72 h after inoculation with 8  104 CFU of S. pneumoniae plus
180 U of hyaluronidase are shown. *, P 0.05
FIG. 2. Brain histology. Representative histologic sections of brain
tissue from WT (A) and IL-10/ (B) mice are shown 24 h after
inoculation with 8  104 CFU of S. pneumoniae plus 180 U of hyal-
uronidase, with a more pronounced inflammatory infiltrate evident in
IL-10/ mice than in WT mice. Hematoxylin and eosin stain was
used. Magnification, 66.
TABLE 1. Bacterial outgrowth in CSF, brain homogenates, and
blood of IL-10/ and WT mice with meningitisa
Sample Time(h)
Bacterial count (CFU/ml)b
IL-10/ mice WT mice
CSF 24 (3.7  0.8)  104 (3.9  1.9)  104
48 (1.0  0.8)  106 (6.1  3.9)  104
72 (1.9  0.9)  105 (3.5  0.9)  105
Brain homogenate 24 (6.7 4.1)  105 (1.2  0.5)  105
48 (4.9  1.9)  106 (1.7  0.9)  106
72 (5.1  4.4)  107 (9.2  5.0)  107
Blood 24 (1.9  0.6)  106 (0.6  0.2)  106
48 (4.7  3.8)  104 (5.8  2.7)  104
72 (1.5  0.9)  106 (2.9  1.9)  105
a Mice were inoculated with 8  104 CFU of S. pneumoniae plus 180 U of
hyaluronidase.
b None of the differences in values between IL-10/ and WT mice were
significant. Data are means  standard errors of the means. P 
 0.05.
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interaction of resident immunocompetent cells and recruited
leukocytes.
In conclusion, these results indicate that IL-10 regulates
cytokine and chemokine production but does not play an es-
sential role in antibacterial host defense during murine pneu-
mococcal meningitis.
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